Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Clinical trial NCT07200830 · RECRUITING

Trial details

NCT number: NCT07200830
Sponsor: Alliance for Clinical Trials in Oncology
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostate Carcinoma Metastatic Prostate Adenocarcinoma Stage IVB Prostate Cancer AJCC v8

Start date: 2026-03-31
Primary completion: 2034-09-09
Enrollment: 1524

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.